CXCL10 and autoimmune disease: Our results on the effect of miR-15a-5p on CXCL10 in ECD are supported by reports that miR-15a-5p also modulates neoplastic and immune/inflammatory characteristics in CML [11] and in the autoimmune disease myasthenia gravis [46].